Sign up to save your podcasts
Or
Share AI Access Brief Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI Access Brief Podcast
AI Access Brief Podcast episodes
- FDA RWD Guidance & CMS Star RatingsEpisode 94 — 27 August 2026Examining the FDA's new RWD guidance, CMS Star Ratings changes, NICE threshold consultation, and EMA's adaptive licensing initiative. A look at the implications for evidence generation and market access.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast12 min
- US Healthcare Access & Pricing ShiftsEpisode 93 — 25 August 2026Examining US healthcare access pressures, novel Alzheimer's treatment implications, insulin pricing precedent, and early-stage HTA alignment.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- HTA Evolution & Digital HealthEpisode 92 — 24 August 2026Examining operational hurdles in CMS Part D redesign, ICER's approach to ultra-orphan therapies, FDA decentralized trials guidance, and NICE's RWE integration.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast7 min
- FDA Accelerations, CMS Models, NICE RWEEpisode 91 — 23 August 2026Examining FDA's accelerated approvals in neurodegeneration, CMS's oncology payment models, NICE's RWE framework evolution, and emerging HTA methodologies in Asia-Pacific.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- US Access Signals & Global ShiftsEpisode 90 — 22 August 2026Profit warnings signal US access challenges, new Alzheimer's formulations reshape HEOR strategies, insulin pricing settlements reveal systemic flaws, and ICER expands evidence frameworks.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast8 min
- Profit Warnings & Pricing PressuresEpisode 89 — 21 August 2026Analyzing HCA's profit warning signaling US healthcare access pressures, SubQ Leqembi's approval impact on HEOR strategies, FTC insulin pricing settlement implications, and ICER's expanded scientific advice program.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast14 min
- HTA Method Shifts & RWE IntegrationEpisode 88 — 20 August 2026Examining evolving regulatory frameworks for real-world evidence, Medicare payment system changes, digital health HTA integration, and emerging sustainability metrics in value assessments.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast11 min
- HCA Warning, SubQ Leqembi, FTC Insulin, ICER AdviceEpisode 87 — 19 August 2026HCA profit warning signals US healthcare access challenges; subQ Leqembi approval transforms Alzheimer's HEOR landscape; FTC insulin settlement reshapes PBM practices; ICER expands scientific advice services.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- HTA Digital Shifts & Pricing PressuresEpisode 86 — 18 August 2026Examining digital health HTA hurdles, emerging market pricing dynamics, blockchain for RWE, and sustainability metrics in value frameworks.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast7 min
- HCA Warning, Leqembi, Insulin, ICEREpisode 85 — 16 August 2026HCA's profit warning signals US healthcare access pressures; subcutaneous Leqembi, FTC insulin settlement, and ICER expansion reshape value strategies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast12 min
About AI Access Brief Podcast
From the publisher's feed
AI Generated Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and…
evidence strategy.